Donate to Cancer Research To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.

100%


Runyon 5K for Cancer Research at Yankee Stadium Runyon 5K
Broadway Tickets Service Best Seats, Great Cause Broadway Tickets
New Cancer Research Treatment Discoveries New Discoveries in Cancer Research



Mailing List Sign Up: Damon Runyon Cancer Research Foundation



Research Results > july 15 2006

July 15, 2006

 John V. Heymach, MD, PhD (Damon Runyon-Lilly Clinical Investigator '04-'09) has provided an expert review on the latest clinical trials with new therapies targeting the Epidermal Growth Factor Receptor (EGFR), a key regulator of growth and survival in a number of tumors including non-small cell lung cancer.